- Design
- Double-blind randomised controlled trial
- Population
- 220 nulliparous women receiving epidural labour analgesia
- Primary outcome
- Incidence of intrapartum fever (38 degrees or more)
- Effect
- Fever 15.5% vs 30.9%, relative risk 0.5 (95% CI 0.30 to 0.84)
Epidural labour analgesia is associated with intrapartum fever, which triggers maternal and neonatal sepsis evaluations. This double-blind randomised trial in 220 nulliparous women tested whether warming the local anaesthetic to body temperature reduces it, comparing 0.075% ropivacaine with sufentanil at 37 degrees against the same solution at 22 degrees.
Fever (temperature of 38 degrees or more) occurred in 15.5% of the warmed group versus 30.9% of the room-temperature group — a relative risk of 0.5 (95% CI 0.30 to 0.84). Maximum temperature was also modestly lower. However, the 50% reduction fell short of the 60% the trial had set as clinically meaningful, and shivering, labour duration and neonatal outcomes did not differ.
Warming the solution is a simple, low-cost adjustment that approximately halved fever incidence here. It is a reasonable step where epidural fever and its downstream workups are a concern, with the caveat that this single trial did not meet its own prespecified bar.
- Double-blind randomised trial, 220 nulliparous women, warmed (37 degrees) vs room-temperature (22 degrees) epidural solution.
- Intrapartum fever occurred in 15.5% vs 30.9%; relative risk 0.5 (95% CI 0.30 to 0.84).
- Maximum temperature was modestly lower with warming (median difference 0.2 degrees).
- Shivering, labour duration and neonatal outcomes did not differ.
- The 50% reduction fell short of the trial's preset 60% threshold for clinical meaningfulness.
Why it matters
Epidural-associated fever drives maternal and neonatal sepsis workups, so a simple way to reduce it has downstream value.
Don't overread it
A single-centre trial that did not meet its prespecified threshold; it supports warming as reasonable, not as established practice.
The statistics, in plain English
A relative risk of 0.5 with an interval below 1.0 is a real halving of fever; the result is statistically significant but missed the larger effect the trial was designed to detect, so the benefit may be smaller than hoped.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free